Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 3rd February 2023
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers seek cats with FIP for new study
Until recently, FIP was an invariably fatal disease, but new research offers hope.
The study aims to improve diagnosis, treatment and prognosis.

A research team at the University of Edinburgh Royal (Dick) School of Veterinary Studies is looking to recruit approximately 100 cats for a new study into feline infectious peritonitis (FIP). 

Cats with either wet or dry FIP can be enrolled in the study as long as they have had their diagnosis confirmed using the ABCD Algorithm and their owners have given written informed consent. Each cat will stay under the care of their GP veterinarian, with support from the study clinicians.

FIP is a viral disease in young cats, and occasionally older ones, caused by a coronavirus. Until recently, it was nearly always fatal, but research into COVID-19 has suggested that GS-441524 and its prodrug remdesivir can successfully be used to treat it. 

However, diagnosing the disease is still difficult. With an effective treatment now available, it is important to create a definitive test to diagnose and monitor the disease.

The researchers plan to evaluate two diagnostic possibilities: acute-phase proteins (APPs) and micro-RNA (mrRNA) in blood and effusions. It is hoped that at least one of these can be used to develop a reliable test for diagnosis, monitoring and prognosis of FIP.

Case histories and owner questionnaires will help the team to assess whether specific APPs and/or miRNA profiles can be used to predict how well a cat will respond to treatment. 

Prof Danièlle Gunn-Moore, part of the research team, said: “I undertook a PhD study into FIP in 1994 because I had seen so many beautiful kittens die from this hideous disease. I never imagined that I would now be able to treat so many of these precious babies so successfully. It really is the most important thing to happen in feline medicine in my lifetime. I am proud to be part of a group of people who are trying to work out the best way to use these drugs.”

More information about the study, including the participant information sheet and consent form, can be found here.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.